CUSIP 604749101 · who reports it, how much, and how much it matters to them
31 of the 720 hedge fund managers we track reported shares of Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) on Form 13F for 30 June 2026. Between them they reported USD 719m. The largest position belongs to Polar Capital LLP, at USD 99m. The manager with the most riding on it is Boone Capital Management, where it is 11.4% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Polar Capital LLP26 funds on PPLI.com | USD 99m | 0.2% |
| 2 | Rock Springs Capital Management2 funds on PPLI.com | USD 93m | 4.6% |
| 3 | Two Sigma Investments35 funds on PPLI.com | USD 81m | 0.1% |
| 4 | Balyasny Asset Management25 funds on PPLI.com | USD 57m | 0.1% |
| 5 | Baker Bros. Advisors2 funds on PPLI.com | USD 52m | 0.3% |
| 6 | Renaissance Technologies13 funds on PPLI.com | USD 52m | 0.1% |
| 7 | Boone Capital Management1 fund on PPLI.com | USD 49m | 11.4% |
| 8 | Adage Capital Management1 fund on PPLI.com | USD 41m | 0.1% |
| 9 | Palo Alto Investors6 funds on PPLI.com | USD 41m | 5.6% |
| 10 | Octagon Capital Advisors1 fund on PPLI.com | USD 40m | 3.6% |
| 11 | Ra Capital Management1 fund on PPLI.com | USD 37m | 0.3% |
| 12 | Perceptive Advisors6 funds on PPLI.com | USD 14m | 0.2% |
| 13 | Capricorn Fund Managers8 funds on PPLI.com | USD 12m | 0.9% |
| 14 | Millennium Management6 funds on PPLI.com | USD 11m | 0.0% |
| 15 | Voleon Capital Management13 funds on PPLI.com | USD 9.7m | 0.2% |
| 16 | Aquatic Capital Management3 funds on PPLI.com | USD 4.3m | 0.1% |
| 17 | Neo Ivy Capital Management1 fund on PPLI.com | USD 4.2m | 1.0% |
| 18 | PFM Health Sciences3 funds on PPLI.com | USD 3.7m | 0.3% |
| 19 | Resolute Capital Asset Partners1 fund on PPLI.com | USD 3.5m | 1.5% |
| 20 | D. E. Shaw & Co.15 funds on PPLI.com | USD 3.3m | 0.0% |
| 21 | Sofinnova Investments1 fund on PPLI.com | USD 3.2m | 0.2% |
| 22 | Jain Global1 fund on PPLI.com | USD 2.5m | 0.0% |
| 23 | HighVista Strategies27 funds on PPLI.com | USD 1.7m | 0.4% |
| 24 | Mangrove Partners Im1 fund on PPLI.com | USD 1.2m | 0.1% |
| 25 | Engineers Gate Manager1 fund on PPLI.com | USD 953,000 | 0.0% |
| 26 | Entrypoint Capital1 fund on PPLI.com | USD 603,000 | 0.1% |
| 27 | Persistent Asset Partners10 funds on PPLI.com | USD 516,000 | 0.2% |
| 28 | Squarepoint Ops7 funds on PPLI.com | USD 339,000 | 0.0% |
| 29 | Prelude Capital Management9 funds on PPLI.com | USD 272,000 | 0.0% |
| 30 | CIBC Asset Management69 funds on PPLI.com | USD 218,000 | 0.0% |
| 31 | The Quarry1 fund on PPLI.com | USD 1,873 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Boone Capital Management | USD 49m | 11.4% |
| 2 | Palo Alto Investors | USD 41m | 5.6% |
| 3 | Rock Springs Capital Management | USD 93m | 4.6% |
| 4 | Octagon Capital Advisors | USD 40m | 3.6% |
| 5 | Resolute Capital Asset Partners | USD 3.5m | 1.5% |
| 6 | Neo Ivy Capital Management | USD 4.2m | 1.0% |
| 7 | Capricorn Fund Managers | USD 12m | 0.9% |
| 8 | HighVista Strategies | USD 1.7m | 0.4% |
| 9 | Ra Capital Management | USD 37m | 0.3% |
| 10 | PFM Health Sciences | USD 3.7m | 0.3% |
Mirum Pharmaceuticals, Inc. trades under the symbol MIRM on the Nasdaq. Its CUSIP, the code used on Form 13F, is 604749101.
31 of the 720 hedge fund managers PPLI.com tracks reported Mirum Pharmaceuticals, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Polar Capital LLP (USD 99m), Rock Springs Capital Management (USD 93m), Two Sigma Investments (USD 81m), Balyasny Asset Management (USD 57m) and Baker Bros. Advisors (USD 52m).
31 managers in our coverage reported it, and between them they run 297 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Boone Capital Management, where the position was 11.4% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Mirum Pharmaceuticals, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.